Skip to content
Subscriber Only
Markets
Prognosis

New Astra Vaccine in Development to Fight South Africa Variant

  • Oxford professor says adapted shot should be ready by autumn
  • Study showed dose less effective against South African strain
Bloomberg business news
Watch: Vaccine developers say they are working on a new shot to combat the South African strain of the coronavirus. (Source: Bloomberg)

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Vaccine developers said they are working on a new shot to combat the South African strain of coronavirus after early data suggested AstraZeneca Plc’s product has limited efficacy against mild disease caused by the variant.